Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 43, Issue 3, 2000, Pages 617-627

  Yudoh, Kazuo ^a   Matsuno, Hiroaki ^a   Nakazawa, Fujio ^a   Yonezawa, Tamon ^a   Kimura, Tomoatsu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DOWN REGULATION; FEMALE; HELPER CELL; HUMAN; HUMAN TISSUE; INFLAMMATION; JOINT INJURY; LYMPHOCYTIC INFILTRATION; MALE; OSTEOARTHRITIS; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYNOVIUM; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-10; LYMPHOCYTES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SYNOVIAL MEMBRANE; TH1 CELLS; TH2 CELLS;

EID: 0034040902     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200003)43:3<617::AID-ANR19>3.0.CO;2-B     Document Type: Article

References (51)

1. Rocha R, von Boehmer H. Peripheral selection of the T cell repertoire. Science 1991;251:1225-8.
2. Nossal GJV. Bone marrow pre-B cells and the clonal anergy theory of immunologic tolerance. Int Rev Immunol 1987;2:321-38.
3. Benacerra B, Germain RNA. A signal major pathway of T-lymphocyte interactions in antigen-specific immune suppression. Scand J Immunol 1981;13:1-10.
4. Jenkins MK, Chen CA, Jung G, Mueller DL, Schwartz RH. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J Immunol 1990;144:16-22.
5. Schwarz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990;248:1349-56.
6. Mason D, Fowell D. T-cell subsets in autoimmunity. Curr Opin Immunol 1992;4:728-32.
7. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-42.
8. Bacchetta R, Bigler M, Touraine J-L, Parkman R, Tovo P-A, Abrams J, et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 1994;493-502.
9. Gorczynski RM, Vojcik D. A role for nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization of transfusion. J Immunol 1994;152:2011-9.
10. Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992;10: 385-409.
11. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994;12:227-57.
12. Mosmann TR, Bond CMW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136: 2348-57.
13. Romangnani S. Th1 and Th2 subsets: doubt no more. Immunol Today 1991;12:256-7.
14. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci U S A 1994;91: 8562-6.
15. Dolhain RJEM, van der Heiden AN, ter Haar NT, Breedveld FC, Miltenburg AMM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1961-9.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
17. Prevoo MLL, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
18. Igarashi H, Sakaguchi N. Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem Biophy Res Commun 1996;219:649-55.
19. Weng N-P, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996;183:2471-9.
20. Kiener HP, Baghestanian M, Dominkus M, Walchshofer S, Ghannadan M, Willheim M, et al. Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis. Arthritis Rheum 1998;41:233-45.
21. Yudoh K, Matsuno H, Nezuka T, Kimura T. Different mechanisms of synovial hyperplasia in rheumatoid arthritis and pigmented villonodular synovitis: the role of telomerase activity in synovial proliferation. Arthritis Rheum 1999;42:669-77.
22. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-34.
23. Rooney M, Condell D, Quinlan W, Daly L, Whelan A, Feighery C, et al. Analysis of the histologic variation of synovitis in rheumatoid arthritis. Arthritis Rheum 1988;31:956-63.
24. Weiner HL, Inobe J, Kuchroo V, Chen Y. Induction and characterization of TGF β secreting cells [abstract]. FASEB J 1996;10A: A1444.
25. Morrissey PJ, Charrier K, Braddy S, Liggitt D, Watson JD. CD4+ T cells that express high levels of CD45RB induce washing disease when transferred into congenic severe combined immunodeficient mice: disease development is prevented by contransfer of purified CD4+ T cells. J Exp Med 1993;178:237-44.
26. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C.B-17 SCID mice. Int Immunol 1993;5:1461-71.
27. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
28. Sadlack B, Merz A, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
29. Van der Graaff WL, Prins APA, Dijmans BAC, van Lie RAW. Prognostic value of Th1/Th2 ratio in rheumatoid arthritis. Lancet 1998;351:1931.
30. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994;180:1961-6.
31. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways; application to autoimmune disease therapy. Cell 1995;80:707-18.
32. Van Roon JA, Verhoef CM, van Roy JL, Gmelig-Meyling FH, Huber-Bruning O, Lafeber FP, et al. Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease. Ann Rheum Dis 1997;56:656-60.
33. Bucht A, Larsson P, Weisbrot L, Thorne C, Pisa P, Smedegard G, et al. Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA). Clin Exp Immunol 1996;103:357-67.
34. Austrup F, Vestweber D, Borges E, Löhning M, Bräuer R, Herz U, et al. P-and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 1997;385:81-3.
35. Howard MA, O'Garra H, Ishida H, de Waal Malefyt R, de Vries JE. Biological properties of interleukin 10. J Clin Immunol 1992;12:239-47.
36. De Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE. Interleukin-10. Curr Opin Immunol 1992;4:314-20.
37. Bejarano MT, de Waal Malefyt R, Abrams JS, Bigler M, Bacchetta R, de Vries JE, et al. Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int Immunol 1992;4:1389-97.
38. De Waal Malefyt R, Abrams J, Bennett B, Figdor C, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
39. Lapadula G, Iannone E, Dell'Accio F, Covelli M, Pipitone V. Interleukin-10 in rheumatoid arthritis. Clin Exp Rheumatol 1995; 13:629-32.
40. Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze-Koops H, Davis LS, et al. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:96-104.
41. Cohen SBA, Katsikis PD, Chu C-Q, Thomssen H, Webb LMC, Maini RN, et al. High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum 1995;38:946-52.
42. Lacki JK, Klama K, Mackiewicz U, Muller W. Circulating interleukin 10 and interleukin-6 serum levels in rheumatoid arthritis patients treated with methotrexate or gold salts: preliminary report. Inflamm Res 1995;44:24-6.
43. Yssel H, de Waal Malefyt R, Roncarolo MG, Abrams JS, Lahesmaa R, Spits H, et al. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 1992;149:2378-84.
44. Seder RA, Paul WE, Davis MM, de St. Groth BF. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med 1992;176:1091-8.
45. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Urayama S, Kawabe Y, et al. Inhibitory effects of interleukin-10 on synovial cells of rheumatoid arthritis. Immunology 1997;91:252-9.
46. Klimiuk PA, Goronzy JJ, Bjornsson J, Beckenhaugh RD, Weyand CM. Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am J Pathol 1997;151:1311-9.
47. Keystone E, Wherry J, Grint P. IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am 1998;24:629-39.
48. Jorgensen C, Apparailly F, Canovas F, Verwaerde C, Auriault C, Jacquet C, et al. Systemic viral interleukin-10 gene delivery prevents cartilage invasion by human rheumatoid synovial tissue engrafted in SCID mice. Arthritis Rheum 1999;42:678-85.
49. Blazar BR, Taylor PA, Smith S, Vallera DA. Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow graft. Blood 1995;85:842-51.
50. Lee M-S, Wogensen L, Shizuru J, Oldstone MBA, Sarvetnick N. Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J Clin Invest 1994;93: 1332-8.
51. Cannella B, Gao YL, Brosnan C, Raine CS. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J Neurosci Res 1994;45:735-46.